Company profile
Rivopharm SA
Rivopharm SA is a Switzerland-based pharmaceutical manufacturer specialising in generic medicines, specialty pharmaceutical formulations, dossier development, and value-added pharmaceutical solutions. Incorporated in 1961 and headquartered in Manno, Canton Ticino, the company develops and manufactures oral solid dosage forms, primarily tablets and capsules, and manages a proprietary portfolio of approximately 125 molecules and nearly 1,500 SKUs distributed across more than 30 countries. Rivopharm operates an FDA-, TGA-, Swissmedic- and EU-approved manufacturing facility in Manno and maintains subsidiaries in the United Kingdom, Germany, and Lithuania.
- Sector
- Healthcare / Biotechnology, Pharmaceuticals
- Founded
- 1961
- Ownership
- Private
- Stage
- Corporate
- Employees
- 201-500
- Business model
- B2B Manufacturing, Licensing
Products and services
Generic oral solid dosage forms, Specialty pharmaceutical dossier development & ANDA (US Generic Drug) products
Transactions
| Date | Transaction | Type | Value | Market |
|---|---|---|---|---|
| 25 Jun 2026 | Laprophan Group acquires majority stake in Rivopharm | Corporate Transactions | Undisclosed |
Source: Partner Researchers.